1. Home
  2. NTRS vs IQV Comparison

NTRS vs IQV Comparison

Compare NTRS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Trust Corporation

NTRS

Northern Trust Corporation

HOLD

Current Price

$172.34

Market Cap

31.1B

Sector

Finance

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$167.48

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRS
IQV
Founded
1889
1982
Country
United States
United States
Employees
23800
93000
Industry
Major Banks
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.1B
28.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NTRS
IQV
Price
$172.34
$167.48
Analyst Decision
Hold
Strong Buy
Analyst Count
12
16
Target Price
$163.55
$227.13
AVG Volume (30 Days)
950.5K
1.5M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
1.94%
N/A
EPS Growth
N/A
4.67
EPS
N/A
1.61
Revenue
N/A
$9,739,000,000.00
Revenue This Year
$8.40
$6.77
Revenue Next Year
$4.13
$5.89
P/E Ratio
$16.88
$104.26
Revenue Growth
N/A
41.60
52 Week Low
$118.99
$154.50
52 Week High
$176.99
$247.05

Technical Indicators

Market Signals
Indicator
NTRS
IQV
Relative Strength Index (RSI) 56.21 39.76
Support Level $165.90 $159.53
Resistance Level $172.36 $182.20
Average True Range (ATR) 4.03 6.35
MACD 0.06 -1.70
Stochastic Oscillator 62.31 19.50

Price Performance

Historical Comparison
NTRS
IQV

About NTRS Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2025, Northern Trust had assets under custody or administration of $18.7 trillion and assets under management of $1.8 trillion.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: